[1]杨 苹,陆 宏,王晓玲.老年慢病患者联合用药的不良反应与识别分析[J].国外医学医学地理杂志,2019,(02):147-150.[doi:10.3969/j.issn.1001-8883.2019.02.014]
 YANG Ping,LU Hong,WANG Xiaoling.Adverse reactions and identification analysis of combinedmedication in elderly patients with chronic diseases[J].Foreign Medical Sciences (Section of Medgeography),2019,(02):147-150.[doi:10.3969/j.issn.1001-8883.2019.02.014]
点击复制

老年慢病患者联合用药的不良反应与识别分析()
分享到:

国外医学医学地理杂志[ISSN:1001-8883/CN:61-1102/R]

卷:
期数:
2019年02期
页码:
147-150
栏目:
预防医学
出版日期:
2019-07-02

文章信息/Info

Title:
Adverse reactions and identification analysis of combinedmedication in elderly patients with chronic diseases
作者:
杨 苹陆 宏王晓玲
(甘肃省小陇山林业实验局职工医院药械科,甘肃天水 741020)
Author(s):
YANG PingLU HongWANG Xiaoling
(Drug and Equipment Department,Staff and Workers Hospital of Xiaolongshan Forestry Experimental Bureau in Gansu Province,Tianshui 741020,China)
关键词:
药房药师 老年慢病患者 联合用药 不良反应 识别
Keywords:
pharmacy pharmacist elderly chronic disease patients combined medication adverse reactions identification
分类号:
R249
DOI:
10.3969/j.issn.1001-8883.2019.02.014
文献标志码:
A
摘要:
目的 调查药房药师对老年慢病患者联合用药不良反应的识别情况,分析相关影响因素。方法 对2017年7月至2018年6月甘肃地区的药房药师99例进行调查,比较药师的一般资料与对联合用药不良反应识别情况,并进行相关分析。结果 100.0%的药师能意识到联合用药不良反应治疗的重要性,识别评分为(3.98±0.56)分,不同职称、工龄、学历、工作科室、接受慢病培训药师的不良反应识别评分对比差异有统计学意义(P<0.05)。Pearson线性相关分析显示药房药师的不良反应识别评分与慢病培训、职称、工作科室、工龄、学历等明显相关(P<0.05)。多因素逐步回归方法分析结果显示慢病培训、职称、工作科室、工龄为主要的危险因素(P<0.05)。结论 药房药师对老年慢病患者联合用药不良反应的识别水平还有待提高,慢病培训、职称、工作科室、工龄为主要的影响因素。
Abstract:
Objective To investigate the recognition and cognition of pharmacists in the adverse reactions of elderly patients with chronic diseases,and to analysis the related influencing factors.Methods From July 2017 to June 2018,a total of 99 pharmacy pharmacists in Gansu Province conducted a survey.To compare the general information of pharmacists with the identification of adverse reactions to combined drugs,and to conduct correlation analysis.Results There were 100.0% of the pharmacists were aware of the importance of the combination therapy,and the recognition score was(3.98±0.56)points.The differences in the scores of adverse reaction recognition scores of different professional titles,seniority,education,work department,and chronic disease training pharmacists were statistically significant(P<0.05).Pearson linear correlation analysis showed that the pharmacist’s adverse reaction recognition score were significantly correlated with chronic disease training,professional title,work department,length of service,and academic qualifications(P<0.05).The results of multi-factor stepwise regression analysis showed that chronic disease training,professional title,work department and length of service were the main risk factors(P<0.05).Conclusion The recognition level of pharmacy pharmacists for adverse drug reaction in elderly patients with chronic diseases needs to be improved.The chronic disease training,professional title,work department and working age are the main influencing factors.

参考文献/References:


[1] Ao M,Xiao X,Li Q.Efficacy and safety of compound kushen injection combined with chemotherapy on postoperative patients with breast cancer:a meta-analysis of randomized controlled trials[J].Medicine(Baltimore),2019,98(3):e14024-e14028.
[2] 李林通,计成,桑剑锋,等.临床药师应用慢病管理系统管理分化型甲状腺癌术后患者的效果及影响[J].药学与临床研究,2017,25(3):275-278.
[3] Bos JM,Kalkman GA,Groenewoud H,et al.Prediction of clinically relevant adverse drug events in surgical patients[J].PLoS One,2018,13(8):e0201645-e0201649.
[4] Chen G.Effects of Shenfu injection on chemotherapy-induced adverse effects and quality of life in patients with advanced nonsmall cell lung cancer:a systematic review and meta-analysis[J].J Cancer Res Ther,2018,14:549-555.
[5] 陈蓉,周磊,秦琼,等.SIMPLE药学服务模式在支气管哮喘、COPD患者慢病管理中的实践及效果研究[J].中国药房,2018,29(10):1400-1403.
[6] Lee JJ,Chu E.The adjuvant treatment of stageⅢ colon cancer:might less be more?[J].Oncology(Williston Park),2018,32(9):437-442.
[7] 黄丽,罗圣平,谭秋红.临床药师在风湿免疫科开展药学服务的体会[J].安徽医药,2019,23(1):189-192.
[8] Quidde J,Pan Y,Salm M,et al.Preventing adverse events of chemotherapy by educating patients about the nocebo effect(RENNO study)-study protocol of a randomized controlled trial with gastrointestinal cancer patients[J].BMC Cancer,2018,18(1):916-919.
[9] 杨丽娟,施楠楠,甄健存.神经内科临床药师药学服务质量提升策略分析[J].中国药业,2017,26(6):78-80.
[10] Wen J,Ma X,Zhang L,et al.Therapeutic efficacy and safety of Shexiang Baoxin Pill combined with trimetazidine in elderly patients with heart failure secondary to ischaemic cardiomyopathy:A systematic review and meta-analysis[J].Medicine(Baltimore),2018,97(51):e13580-e13584.
[11] 潘威,李明哲.临床药师参与2型糖尿病患者慢病管理指导效果分析[J].四川医学,2016,37(10):1087-1090.
[12] 施楠楠,甄健存,谢颖,等.临床药师慢病管理工作模式的探讨[J].临床药物治疗杂志,2015,13(1):83-86.
[13] Yang Y,Lu ZS,Zeng Z.Clinical efficacy and safety of combination of abraxane and trastuzumab in treatment of recurrent ovarian cancer[J].Pak J Pharm Sci,2018,31(6):2831-2834.
[14] Zheng Y,Peng H,Zhang X,et al.Predicting adverse drug reactions of combined medication from heterogeneous pharmacologic databases[J].BMC Bioi,2018,19(19):517-519.
[15] 李全志,甄健存,潘鹏玉,等.临床药师主导慢病管理对改善2型糖尿病患者临床指标的前瞻性随机对照研究[J].临床药物治疗杂志,2015,13(6):29-33.

备注/Memo

备注/Memo:
收稿日期:2018-12-25 修回日期:2019-02-11
作者简介:杨苹(1974-),女(汉族),大学本科,主管药师.研究方向:西药的管理和监督以及合理用药.
更新日期/Last Update: 2019-07-02